GI Effects Digestive Stool Test
The Most Comprehensive Stool Test for Optimal Clinical Utility
Genomedix stool profiles provide a more complete evaluation of gut health.
Our testing provides information on inflammation and how well you digest and absorb your food. Stool testing can also uncover imbalances in yeast, parasites, and healthy and unhealthy bacteria that live in the large intestine. This bacterial population is called the microbiome.
Systemic diseases can be linked to the GI tract and improving the health of your gut may improve your overall health. Identifying abnormalities through Genomedix testing allows us to develop a personalised treatment plan to improve your symptoms.
GI Effects stool testing might be right for you if you struggle with:
Gas
Bloating
Abdominal pain/cramps
Indigestion/reflux
Diarrhoea
Constipation
Food Allergies
Inflammatory Bowel Disease (Crohn's disease, Ulcerative colitis)
Irritable Bowel Syndrome (IBS)
Looking for added insight?
Symptoms of conditions can overlap. Certain disease states can influence other body systems. Additional testing can help identify those abnormalities.
Recommended add on for a Complete Comprehensive Gut Health Test.
Genomedix Antibody testing helps to identify the body's immune response to foods and environmental triggers with a simple blood draw. Some symptoms happen immediately after eating that food, while others may be delayed by several hours or days. It can be challenging to connect these delayed food reactions back to the problematic food; testing can help uncover these "hidden" food sensitivities.
There are many diverse symptoms and conditions that can result from food reactions:
Gut symptoms such as diarrhoea, gas, constipation, cramps, vomiting, etc.
Irritable Bowel Syndrome (IBS)
Allergic symptoms such as sneezing, itchy eyes, sinus pain, wheezing, etc.
Depression
Migraine headaches
Skin rashes such as eczema or hives
Joint aches
Autoimmune disease
Crohn's Disease
Obesity
Every food test comes with a personalised summary of reactive foods. This can help our clinician develop a tailored food plan specific to your needs and symptoms.
Preparing for this Test
Certain medications, supplements, and/or foods may impact test results. Please note that the reference ranges were established based on patients who were taking no medications or supplements. In some instances it is unknown what potential impact a medication may have on test results.
There may be times when a patient may stay on a medication or dietary supplement during testing in order to evaluate its effectiveness. The recommendation to discontinue any substance is intended to establish a baseline finding. Below you will find a list detailing the potential interference or influence of certain substances on the biomarkers.
Genomedix never recommends that patients discontinue medically necessary medications or supplements in order to complete testing.
Illness
We do not suggest collecting during an acute gastrointestinal infectious illness.
Paediatric Patients
We do not generally recommend stool testing in children under the age of two as they are still establishing their gut flora which can impact numerous findings on the test. Inflammatory markers, such as calprotectin and lactoferrin, can also be skewed in younger children, especially if they are still breastfeeding. Reference ranges for many of the markers have not been established for this population.
Genomedix will not accept add-on testing for Clostridium difficile in individuals less than 2 years old based on recent research indicating non-pathogenic colonization in this age group.
Feacal Occult Blood Testing
If the patient has a bleeding hemorrhoid(s) or is menstruating, it may interfere with the feacal occult blood test. It is preferred that the patient collect samples when there is not active bleeding.
Colectomy and Colostomy
Genomedix stool profiles and reference ranges were not designed with this patient population taken into account. Test results and applicability for a patient who has had a complete or partial colectomy is unknown. Removal of the colon would be expected to impact the microbiome portion of the test, as the colon is the site where the majority of the bacteria reside. The metabolic by-products made by these bacteria may also be impacted. However, there may be clinical value in some of the other biomarkers on the test regarding inflammation and digestion/absorption. It would also be useful to see if there are any pathogenic or potentially pathogenic organisms present.
References
D'Ostroph A, So T. Treatment of paediatric Clostridium difficile infection: a review on treatment efficacy and economic value. Infect Drug Resist. 2017;10:365-375.
